NET INCOME (LOSS) PER SHARE OF COMMON STOCK (Tables)

9 Months Ended

Sep. 30, 2023

Schedule of Company's Basic and Diluted Net Income Per Share and Weighted Average Shares Outstanding

The Company’s basic and diluted net income (loss) per share calculations using the “two-class” method for the three month and nine month periods ended September 30, 2023 and 2022 are presented below:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Net income (loss) attributable to Lazard Ltd	$	7,139	$	105,797	$	(139,046)	$	315,153
Add - adjustment for earnings attributable to participating securities	(1,029)		(1,903)		(2,917)		(4,726)
Net income (loss) attributable to Lazard Ltd - basic	6,110		103,894		(141,963)		310,427
Add - adjustment for earnings attributable to participating securities	-		635		-		2,318
Net income (loss) attributable to Lazard Ltd - diluted	$	6,110	$	104,529	$	(141,963)	$	312,745
Weighted average number of shares of common stock outstanding	87,067,104		91,742,376		86,529,833		96,585,793
Add - adjustment for shares of common stock issuable on a non-contingent basis	2,358,796		1,533,255		2,052,635		1,575,234
Weighted average number of shares of common stock outstanding - basic	89,425,900		93,275,631		88,582,468		98,161,027
Add - dilutive effect, as applicable, of:
Weighted average number of incremental shares of common stock issuable from share-based incentive compensation (a)	4,883,324		5,589,525		-		5,107,351
Weighted average number of shares of common stock outstanding - diluted	94,309,224		98,865,156		88,582,468		103,268,378
Net income (loss) attributable to Lazard Ltd per share of common stock:
Basic	$	0.07	$	1.11	$	(1.60)	$	3.16
Diluted	$	0.06	$	1.06	$	(1.60)	$	3.03

___________________________________

(a)The aggregate weighted average number of incremental shares of common stock issuable from RSUs, PRSUs and profits interest participation rights for the nine month period ended September 30, 2023 of 4,785,903, that could be potentially dilutive in future periods, have been excluded from the computation of diluted net loss per share as the effect would be antidilutive in the current periods.